Echo Therapeutics, Inc. (ECTE.OB) Completes Development of Patented SkinPrep System
Echo Therapeutics Inc., a Massachusetts based medical device and specialty pharmaceuticals company, announced today that they have completed product development of their revolutionary PreludeTM SkinPrep System. The product will now go into final clinical trials, and, subject to FDA market clearance, the product will be sold commercially with no further changes. The Prelude SkinPrep System is a skin preparation platform technology used for needle-free transdermal drug delivery, designed for use with novel topical reformulations of widely used FDA approved products. Prelude will be tested using LMX4 lidocaine cream, which should form the basis for a 510-K filing with Ferndale Pharma…